Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04488003 |
|---|---|
| Brief Title: | Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations |
| First Submitted : | July 17, 2020 |
| First Submitted that Met QC Criteria : | July 24, 2020 |
| First Posted : | July 27, 2020 |
| Last Update Submitted that Met QC Criteria : | December 20, 2022 |
| Last Update Posted : | December 21, 2022 |